Mycophenolate mofetil for treatment of active inflammatory bowel disease -: Clinical and immunological studies

被引：6

作者：

Neurath, MF ^{[1
]}

Wanitschke, R ^{[1
]}

Peters, M ^{[1
]}

Hildner, K ^{[1
]}

Tufan, R ^{[1
]}

zum Büschenfelde, KHM ^{[1
]}

Schlaak, JF ^{[1
]}

机构：

[1] Univ Mainz, Med Clin 1, Immunol Lab, Dept Med 1, D-55101 Mainz, Germany

来源：

INTESTINAL PLASTICITY IN HEALTH AND DISEASE | 1998年 / 859卷

关键词：

D O I：

10.1111/j.1749-6632.1998.tb11154.x

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：315 / 318

页数：4

共 50 条

[31] Microbiological and immunological strategies for treatment of inflammatory bowel disease [J].

Steidler, L .

MICROBES AND INFECTION, 2001, 3 (13) :1157-1166

[32] Mycophenolate mofetil - A useful immunosuppressive in inflammatory eye disease [J].

Larkin, G ;

Lightman, S .

OPHTHALMOLOGY, 1999, 106 (02) :370-374

[33] Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease [J].

Cuchacovich, Miguel ;

Solanes, Federica ;

Perez, Claudio ;

Ignacio Verdaguer, Juan ;

Verdaguer, Juan ;

Castiglione, Enzo ;

Carpentier, Cristian ;

Traipe, Leonidas ;

Villarroel, Francisco .

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (01) :55-61

[34] Mycophenolate mofetil: implications for the treatment of glomerular disease [J].

Badid, C ;

Desmouliere, A ;

Laville, M .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (09) :1752-1756

[35] Successful mycophenolate mofetil treatment of glomerular disease [J].

Briggs, WA ;

Choi, MJ ;

Scheel, PJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (02) :213-217

[36] Mycophenolate mofetil treatment of glomerular disease. [J].

Briggs, WA ;

Choi, M ;

Scheel, PJ ;

Onuchic, LF ;

Mathew, S .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 :A0396-A0396

[37] Efficacy and limits of immunomodulators in inflammatory bowel disease:: azathioprine, 6-mercaptopurine, methotrexate and mycophenolate mofetil [J].

Gassull, MA ;

Cabré, E ;

Domenech, E .

IMMUNOLOGICAL DISEASES OF LIVER AND GUT, 2004, 135 :249-260

[38] Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry [J].

Hernandez-Camba, A. ;

Arranz, L. ;

Vera, I ;

Carpio, D. ;

Calafat, M. ;

Lucendo, A. J. ;

Taxonera, C. ;

Marin, S. ;

Garcia, M. J. ;

Marin, G. Suris ;

Rodriguez, E. Sanchez ;

Carbajo, A. Y. ;

De Castro, M. L. ;

Iborra, M. ;

Martin-Cardona, A. ;

Rodriguez-Lago, I ;

Busquets, D. ;

Bertoletti, F. ;

Ausin, M. Sierra ;

Tardillo, C. ;

Malaves, J. Huguet ;

Bujanda, L. ;

Castano, A. ;

Domenech, E. ;

Ramos, L. .

DIGESTIVE AND LIVER DISEASE, 2022, 54 (05) :635-641

[39] MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF INFLAMMATORY MYOPATHY RELATED INTERSTITIAL LUNG DISEASE: A SYSTEMATIC REVIEW [J].

Lopez, B. ;

Isenberg, D. A. ;

Gordon, P. A. .

ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 :1265-1265

[40] Mycophenolate mofetil following intolerance or failure of thiopurine therapy in inflammatory bowel diseases [J].

McDermott, E. ;

Keegan, D. ;

Hall, B. ;

Mhuruchu, E. N. ;

Murphy, S. ;

Doherty, G. ;

O'Donoghue, D. ;

Mulcahy, H. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) :1040-1042

← 1 2 3 4 5 →